Fabry disease trials in Spain

In Spain 5 Also abroad 48

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Where
Madrid
Age
2 years to 11 years
People
8 worldwide
Run by
Amicus Therapeutics
See details and how to joinNCT06904261
No phaseTaking people
Fabry Disease Registry & Pregnancy Sub-registry
Where
A Coruña, Barcelona, Bizkaia, L'Hospitalet de Llobregat, Tarragona, Vigo
People
9,000 worldwide
Run by
Genzyme, a Sanofi Company
See details and how to joinNCT00196742
Phase 2/3Taking people
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Where
Santiago de Compostela
Age
2 years to 17 years
People
22 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06328608 · EU 2022-503128-29-00
Phase 3Not yet taking people in Spain
An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12-month Treatment with Migalastat in Pediatric Subjects (aged 2 to < 12 years) with Fabry Disease and Amenable GLA Variants
Where
Madrid
Age
Up to 17 years
People
3 worldwide
Run by
Amicus Therapeutics Inc.
See details and how to join2025-521244-38-00 · EU 2025-521244-38-00
No phaseTaking people
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Where
Madrid
People
10 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT06941025